-
Founded in:
1999-01-28 -
Country:
China -
Address:
No. 1001, Middle Section of Tongge Street, Xiaohe Industrial Park, Shanxi Transformation and Comprehensive Reform Demonstration Zone -
Tax NO.:
91140100713652658Q -
Registered Funds:
66 million yuan -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Tetracycline hydrochloride |
This product is a broad-spectrum antibacterial agent, with bactericidal effect at high concentrations. It has antibacterial effects on Streptococcus pneumoniae, hemolytic Streptococcus, Streptococcus viridans and some Staphylococci, Clostridium perfringens, Bacillus anthracis, Bacillus plague, Corynebacterium diphtheriae, Corynebacterium tetani, Brucella, Haemophilus influenzae, Campylobacter, Vibrio cholerae, etc. It also has inhibitory effects on Rickettsia, Mycoplasma, Chlamydia, Spirochete, and some protozoa. This product has better effects on Gram-positive bacteria than Gram-negative bacteria, but Enterococcus is resistant to it. In addition, it is also sensitive to Actinomyces, Bacillus anthracis, Listeria monocytogenes, Clostridium, Nocardia, etc. The mechanism of action is that the drug can specifically bind to the A position of the 30S subunit of the bacterial ribosome, preventing the connection of aminoacyl-tRNA at this position, thereby inhibiting the growth of the peptide chain and affecting the synthesis of bacterial proteins.
More
This product is a broad-spectrum antibacterial agent, with bactericidal effect at high concentrations. It has antibacterial effects on Streptococcus pneumoniae, hemolytic Streptococcus, Streptococcus viridans and some Staphylococci, Clostridium perfringens, Bacillus anthracis, Bacillus plague, Corynebacterium diphtheriae, Corynebacterium tetani, Brucella, Haemophilus influenzae, Campylobacter, Vibrio cholerae, etc. It also has inhibitory effects on Rickettsia, Mycoplasma, Chlamydia, Spirochete, and some protozoa. This product has better effects on Gram-positive bacteria than Gram-negative bacteria, but Enterococcus is resistant to it. In addition, it is also sensitive to Actinomyces, Bacillus anthracis, Listeria monocytogenes, Clostridium, Nocardia, etc. The mechanism of action is that the drug can specifically bind to the A position of the 30S subunit of the bacterial ribosome, preventing the connection of aminoacyl-tRNA at this position, thereby inhibiting the growth of the peptide chain and affecting the synthesis of bacterial proteins. |
64-75-5 | 30 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| PAEONIAE RADIX ALBA |
|
0 | ||
| DGL |
|
0 | ||
| Cmnamomi Mmulus |
|
0 | ||
| Alpiniae Officinarum Rhizoma |
|
0 | ||
| COPTIDISRHIZOMA |
|
0 | ||
| Bupleurum |
|
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Glibenclamide |
Mainly stimulates pancreatic β cells to secrete insulin to produce blood sugar lowering effect
More
Mainly stimulates pancreatic β cells to secrete insulin to produce blood sugar lowering effect |
1.25mg | 10238-21-8 | 28 |
| 1，1-DIMETHYLBIGUANIDE HYDROCHLORIDE |
It can reduce the production of liver glycogen, reduce intestinal absorption of sugar, and improve insulin sensitivity by increasing peripheral sugar uptake and utilization
More
It can reduce the production of liver glycogen, reduce intestinal absorption of sugar, and improve insulin sensitivity by increasing peripheral sugar uptake and utilization |
250mg | 15537-72-1 | 55 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Sulfamethoxazole |
This product is a sulfonamide antibiotic. When used in combination with trimethoprim, it can double block the bacterial folic acid metabolism and enhance the synergistic antibacterial effect, especially the antibacterial effect on Escherichia coli, Haemophilus influenzae, and Staphylococcus aureus is significantly enhanced compared with a single drug.
More
This product is a sulfonamide antibiotic. When used in combination with trimethoprim, it can double block the bacterial folic acid metabolism and enhance the synergistic antibacterial effect, especially the antibacterial effect on Escherichia coli, Haemophilus influenzae, and Staphylococcus aureus is significantly enhanced compared with a single drug. |
100mg | 723-46-6 | 33 |
| Trimethoprim |
This product is a sulfonamide antibiotic. When used in combination with sulfamethoxazole, it can double block the bacterial folic acid metabolism, enhance the synergistic antibacterial effect, and reduce drug-resistant strains.
More
This product is a sulfonamide antibiotic. When used in combination with sulfamethoxazole, it can double block the bacterial folic acid metabolism, enhance the synergistic antibacterial effect, and reduce drug-resistant strains. |
20mg | 738-70-5 | 44 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Ranitidine Hydrochloride |
It has the effect of competitively blocking the binding of histamine to H2 receptors and inhibiting the effect of gastric acid. Its molarity is 5 to 12 times that of cimetidine, making it a potent H2 receptor blocker.
More
It has the effect of competitively blocking the binding of histamine to H2 receptors and inhibiting the effect of gastric acid. Its molarity is 5 to 12 times that of cimetidine, making it a potent H2 receptor blocker. |
66357-59-3 | 49 |